Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Synageva BioPharma and Mitsubishi Tanabe Pharma expand collaboration

April 3, 2012

BioSeek and Merck Serono extend BioMAP collaboration

March 29, 2012

FDA issues first-of-a-kind guidance on premarket review of medical devices

March 28, 2012

Bayer HealthCare and Tsinghua University extend drug discovery partnership

March 28, 2012

New technology launched by arGEN-X

March 21, 2012

Marina Biotech and ProNAi Therapeutics enter license agreement for DNAi-based therapies

March 16, 2012

FDA approves first effervescent osteoporosis drug

March 15, 2012

Amorfix announces new technology acquisition

March 13, 2012

New nanovector platform allows noncovalent assembly of targeted therapeutics

March 12, 2012

Nuvilex provides information on cell encapsulation technology

March 12, 2012

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...